Watchlists Portfolios Alerts Pricing Sign in Get started

Menu

Nuo Therapeutics, Inc. AURX

Full chart Compare

Set alert

1.07 USD 0.00 (+0.00%)

At closeNov 9, 2026, 4:00 PM EST

1.07 Day range 1.07

0.77 52-week range 2.92

YTD: -45.69%
1 year: -58.04%

News

2 months ago globenewswire.com Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update D ifferentiated Autologous PRP Remains Well-Positioned for Attractive Long-Term Growth HOUSTON, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial-stage…
6 months ago globenewswire.com Nuo Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update HOUSTON, May 14, 2026 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial-stage medical device company focused on developing and marketing regenerative therapies for…
1 year ago globenewswire.com Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on…
1 year ago globenewswire.com Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies HOUSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Wound care patients across the PAM Health network of hospitals and outpatient clinics will now have access to an innovative new treatment to accelerate…